China
Africa
Explore chapters and articles related to this topic
Breast Imaging with 99mTc-Tetrofosmin
Published in Raymond Taillefer, Iraj Khalkhali, Alan D. Waxman, Hans J. Biersack, Radionuclide Imaging of the Breast, 2021
Enrico del Vecchio, Luigi Mansi, Pier Francesco Rambaldi, Vincenzo Cuccurullo, Biagio Pecori, Mario Quarantelli, Decio Capobianco, Marco Bresciani
The analysis of axilla has to be done in studies acquired with arm raised (Fig. 6A). A comparison with contralateral axilla and the evaluation of the possibility of aspecific uptake due to extravasation at the injection site are mandatory.
Transfer of vascularized lymph node tissue
Published in Steven J. Kronowitz, John R. Benson, Maurizio B. Nava, Oncoplastic and Reconstructive Management of the Breast, 2020
Steven J. Kronowitz, John R. Benson, Maurizio B. Nava
Anastomosis within the axilla is normally performed between donor vessels of the circumflex scapular system following debridement of fibrotic tissue. It is essential to position the lymph nodes at the apex of the axilla in contact with axillary tissue as this is the site where dominant afferent lymphatic channels arrive from the arm.
Breast Cancer
Published in Andrew Stevens, James Raftery, Breast Cancer Health Care Needs Assessment, 2018
Primary surgical treatment may be by mastectomy or BCT with post-operative radiotherapy. Axillary lymph nodes are surgically excised for pathological assessment. Disease in the axillary lymph nodes is treated by surgery or radiotherapy.56
Microwave ablation without subsequent lumpectomy versus breast-conserving surgery for early breast cancer: a propensity score matching study
Published in International Journal of Hyperthermia, 2023
Yu-qing Dai, Ping Liang, Jiandong Wang, Yan-chun Luo, Xiao-Ling Yu, Zhi-Yu Han, Fang-yi Liu, Xin Li, Shui-lian Tan, Zhen Wang, Chong Wu, Jian-ming Li, Jie Yu
In the MWA group, patients chose MWA for poor physical condition (14/21, 67%) and reluctance to surgery (7/21, 33%). Twenty-one patients with 28 lesions received 23 MWA sessions, and all achieved technique success. Six malignant lymph nodes of five patients were ablated (including four patients with one lymph node each and one patient with two). Nineteen patients underwent MWA in one session. Two patients underwent a second ablation for the residual lesions assessed by CEMRI within three days of MWA. The maximum diameter of the primary tumor was 4.9 cm and 5.0 cm in both patients. Compared to BCS, fewer patients in the MWA group received chemotherapy (before PSM: 14% vs 62%, p = 0.004; after PSM: 14% vs 48%, p = 0.02) and radiation therapy (before PSM: 14% vs 88%, p = 0.04; after PSM: 14% vs 81%, p < 0.001) for their poor tolerance (Table 2). In the BCS group, 85 patients with 86 lesions before PSM and 21 patients with 26 lesions after PSM all achieved technique success within one procedure. 24% (20/85) of patients performed axillary lymph node dissection (ALND) according to the pathological results of SLN.
Is the TCH-P regimen active in early or locally advanced HER2-positive breast cancer? Results of a retrospective study
Published in Acta Oncologica, 2022
Raffaele Longo, Victoire Thiebaut, Pierre-Olivier Legros, Marco Campitiello, Francesca Plastino, Christophe Goetz, Bogdan Margineanu, Julie Pujois, Michel Gunther, Julie Egea, Chloé Wendel
A clinical/radiological complete response was found in 6 patients (31.8%). Twelve patients (63.6%) presented a partial response and only 1 patient (5.3%) showed a local progression, but this patient achieved a pCR after surgery. The pathological tumor and lymph node response is reported in Figure 1. A primary tumor and lymph node pCR was achieved by 13 (68.9%) and 16 (84.8%) of the patients, respectively. Thirteen patients (68.9%) achieved a ypT0/is and ypN0 tumor response. Two patients (10.6%) presented a partial tumor and lymph node response and 3 patients (15.9%) a partial primary tumor and a complete lymph node response. Only one patient (5.3%) did not show any tumor and/or lymph node response. Subtype analysis showed a higher pCR rate in HR- tumors (Figure 1) and in patients with a Ki-67 grade > 20% (Figure 2). Among the 2 patients with a HER2 2+ score, one reported a pCR and one a partial primary tumor and a complete lymph node response (Figure 3). Breast-conserving surgery was done in 7 patients (37.1%). Twelve patients (63.6%) underwent a radical mastectomy. A radical axillary lymph node dissection was performed in 12 patients (63.6%). All patients received adjuvant radiotherapy and 10 patients (53%) a post-surgery hormonotherapy. T-DM1 vas administered in only one patient (5.3%) who did not achieve a pCR.
Association of BMI and lipid profiles with axillary osmidrosis: a retrospective case-control study
Published in Journal of Dermatological Treatment, 2021
Zheng Dong, Zhen Tan, Zhenyu Chen
Axillary osmidrosis (AO) is an offensive odor produced by human armpit, which is mainly related to the secretion activity of apocrine glands. The incidence of AO in China is about 4% to 8%, and there is no report on the prevalence of AO in foreign countries. Although the odor does not affect the survivor life, the offensive odor affects the daily life and normal social of the patient seriously and brings great psychological pressure to the patient (1). The current clinical treatment of AO is mainly to block the production of odor, including surgical and non-surgical treatment. Surgical has proven to be the most effective treatment (2). The method of surgical is to remove all or most of the apocrine glands (3). Although the surgical method is continuously improved, the incision is large, the wound treatment is complicated, and the local skin flap necrosis and local hematoma are high. There are also risks of scar hyperplasia and recurrence of AO. The second operation not only brings more incision, but the hyperplasia of the scar causes the residual apocrine sweat glands to merge with the hyperplastic tissue, which is difficult to remove. Completely common non-surgical methods include: odor neutralizer treatment, suitable for mild patients, and such treatments are palliatives. Some patients with critical or mild patients require surgery to treat AO radically. In the above two cases, the purpose of our study was to research the effect of BMI on the incidence and postoperative efficacy of AO, to provide a new idea for treating critical or mild odor and reducing the incidence of secondary surgery.